FDA approves new device aimed at easing stroke risk
(HealthDay)—A new technology designed to reduce stroke risk in certain patients has been approved by the U.S. Food and Drug Administration, the agency announced Monday.
Feb 9, 2015
0
5
(HealthDay)—A new technology designed to reduce stroke risk in certain patients has been approved by the U.S. Food and Drug Administration, the agency announced Monday.
Feb 9, 2015
0
5
(HealthDay)—Millions of Americans aged 65 and older fall every year, according to the U.S. Centers for Disease Control and Prevention. But, fewer than half tell their doctor, according to a news release issued by the Penn ...
Jan 28, 2015
0
13
Falls in blood pressure and total cholesterol staved off more than 20,000 deaths from coronary heart disease in England between 2000 and 2007, shows a mathematical analysis published in the online journal BMJ Open.
Jan 22, 2015
0
11
(HealthDay)—U.S. Food and Drug Administration approval of the anti-cancer drug Cyramza (ramucirumab) has been expanded to include aggressive non-small-cell lung cancer (NSCLC), the agency said Friday.
Dec 14, 2014
0
0
(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.
Dec 3, 2014
0
0
(HealthDay)—A six-year study of people with type 2 diabetes found that intensively lowering blood pressure had a long-lasting effect in preventing heart attacks, strokes and deaths. But intensive blood sugar control didn't ...
Sep 19, 2014
0
0
(HealthDay)—A relatively small number of medications are responsible for sending thousands of young children to the hospital for accidental ingestion, a U.S. government study finds.
Sep 15, 2014
0
0
Lowering the drug threshold for high blood pressure has exposed millions of low-risk people around the world to drug treatment of uncertain benefit at huge cost to health systems, warn US experts in BMJ today.
Sep 14, 2014
0
0
About 100 drugs already approved by the U.S. Food and Drug Administration (FDA) for other purposes can also prevent the growth of certain bacterial pathogens inside human cells, including those that cause Legionnaires' disease, ...
Jul 29, 2014
0
0
(HealthDay)—Whether drugs used to treat attention deficit hyperactivity disorder boost the risk of heart conditions in children remains a subject of concern. Now, research from Denmark suggests medications such as Ritalin ...
Jul 4, 2014
0
0